Microdosing and ayahuasca: now the journey comes with a booking
One person’s experience changes their life. Then somebody sells a new life to somebody else. Between them sit science, ancestral knowledge, care and a fair amount of unlabelled baggage.
Once, people travelled far to get a little lost. Now you can book a transformation with breakfast, integration and flexible cancellation.
The psychedelic journey has entered two very different calendars. In one, a microdose sits between coffee and a video call, promising creativity without leaving Excel. In the other, ayahuasca occupies an entire weekend and comes with a health form, a ceremony, a blanket and a Monday that may still not know what happened.
Some people find that helpful. An experience may reopen a conversation that had been closed for years, reorganize a story or make asking for support possible. That benefit is not diminished by acknowledging that other people notice little, become frightened or return with more questions than luggage.
They share a cultural conversation, but they are not the same. A psilocybin microdose, a full dose in a clinical trial and a traditional Amazonian preparation containing DMT and beta-carbolines cannot be stacked under the word “psychedelic” and shaken as though they were formats of the same app.
Nor should we choose between two caricatures: miraculous medicine with ambient music or instant madness from an old news report. There are promising scientific signals, null results, risks, traditional knowledge and a Western market with an extraordinary ability to arrive before the answers.
The market can sell as transformation something that still needs time to be understood. Recognising that risk does not mean dismissing the experience or the person seeking it.
My travels involved curiosity, conversations and a wish to find other ways of living. Over time, I began to distinguish what I had learned from what I had only imagined doing when I got home.
The small dose and the huge promise
Microdosing usually appears as the adult way to avoid a trip: small amounts on regular days and a discreet improvement in mood, focus or creativity. It is a perfect proposal for our time. It does not ask us to stop the machine; it promises to lubricate it.
Controlled evidence still does not support the breadth of that promise. Trials are small, and clear, consistent improvements over placebo have not appeared. That does not make every reported effect imaginary. It simply keeps two statements apart: “it helped me” and “we know that it produces this benefit”.
Someone can be interested in a new substance and also be considering a break from cannabis. Those are different questions. If they want to observe what happens without joints, adding another substance can complicate that observation.
Curiosity deserves better than calling everything we do not yet understand a shortcut.
The plant did not come alone
Ayahuasca belongs to another story. It is not an invention of the psychedelic industry or a molecule waiting for the West to discover it. It forms part of traditional systems of knowledge and practice among Amazonian peoples, where the preparation, ceremony, community, territory and person guiding it are not interchangeable accessories.
Saying “ancestral knowledge” requires more than adding leaves to a website. Community, territory, rights and the protection of knowledge belong in the conversation. The word ancestral is not a legal air freshener.
Research from Barcelona includes both perceived benefits and difficult experiences. It does not prove that a ceremony cures, or that every risk ends badly. It reminds us that preparation, mental health, support and integration substantially change the setting.
Clinical trials do not hand over a substance and leave it to work as an autonomous therapist. They select, prepare, accompany and follow up. The substance may be central. The surrounding infrastructure is not decoration.
Monday takes part too
An intense experience can open emotions or reorganize a story. It can also destabilize somebody, interact with medication or leave material that is difficult to integrate. That does not fit inside a slogan about “natural medicine”.
The legal position in Spain cannot be summarised as “it is legal”. One acquittal does not create a general regulatory framework. Legal, traditional, therapeutic and safe are four different questions.
Before booking, expectations, personal history, medication, who will accompany you and what happens on Monday all matter. ALO offers no protocol or guide for choosing ceremonies: this subject needs fewer universal instructions and more context.
After a break, there may be different decisions: continuing without cannabis, cutting back or seeking other support. Considering an experience or a product requires its own context; completing 21 days does not make it the next step.
Growing plants, cooking, practising yoga and using a psychoactive substance are not the same activity. They may share curiosity and people, but their effects and the care they require are not interchangeable.
Curiosity deserves better than fear or advertising. Before adding another solution, there is one small question: what do I expect it to do for me?
A cultural and harm-reduction essay supported by sources available on 13 August 2026. Psilocybin microdosing and ayahuasca are not equivalent practices. This text does not recommend using either, offer protocols or replace medical, psychological or legal assessment. If you have a mental health history, take medication or have had a difficult reaction, seek appropriate professional support. If you find information that should be corrected, you can write to ALO.
Sources and editorial criteria
- Cavanna et al.: double-blind study of psilocybin microdosing. This small study of 34 participants found subjective effects and EEG changes, but no evidence of improved well-being, creativity or cognition.
- Kaertner et al.: expectations and microdosing. In this prospective naturalistic study, initial expectations predicted some outcomes. That does not prove that every reported effect is placebo.
- Controlled low-dose LSD study (2024). It is included as a contrast, not to equate LSD with psilocybin. Its controlled results are more modest than many commercial promises.
- EDADES 2024. It is used only for public prevalence data, so media visibility is not confused with majority use; it does not determine the essay’s editorial interpretation.
- Bouso et al.: adverse effects in the Global Ayahuasca Survey. This large international sample was self-selected and retrospective. It describes physical and mental effects, support needs and the relevance of context; it does not prove efficacy or represent every user.
- Dos Santos, Balthazar, Bouso and Hallak: systematic review of human ayahuasca research. The review describes a promising but limited field with small samples and heterogeneous designs.
- José Carlos Bouso’s professional profile at Synaptica, his academic profile for Ayahuasca 2026 and Fundación CANNA’s archive. These pages provide context about his trajectory, current practice and links to the field. They are clinical, conference and sector sources, not substitutes for research or systematic reviews.
- Systematic thematic review of adverse events and toxicity. It incorporates trials, pharmacovigilance and cases and contributes safety counterweight without presenting rare events as an inevitable outcome.
- Pharmacological review of ayahuasca and interactions. It explains the combination of DMT and beta-carbolins that inhibit MAO-A and why concomitant medication requires care.
- WHO Global Traditional Medicine Strategy 2025–2034. It is cited only to document institutional recognition of Indigenous rights, protection of knowledge, sustainability and fair sharing of benefits. It is not treated as a cultural authority or as clinical evidence.
- ICEERS on TSJM Ruling 316/2025 and its 2026 criminal-law analysis. ICEERS is a specialist organization involved in defending these practices. The sources add context; they are not official rulings or legal guarantees.
- Spanish Criminal Code, Article 368. The official text establishes the legal framework, but it does not by itself settle how the law applies to a particular case or answer the essay’s scientific and editorial questions.